VAR2 Pharma’s CEO, Dr. Ali Salanti, receives the preclinical Kirsten & Freddy Johansen Foundation (KFJ) Award for his life-long contribution to research. With the Award comes 2M DKK to continue the work on moving the preclinical assets forward to the patients at most need.
Read more: